YH23537

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YH23537, covering 2019-01-16 to 2019-01-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease. [Phase 2]